Who owns ACURX PHARMACEUTICALS INC?
- Ticker: ACXP
- CUSIP Number: 00510m104
Tip: Access positions for across all investors
Analyze quarterly positions in Acurx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Acurx Pharmaceuticals stock
Who bought or sold ACURX PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 406k | $1.6M | 235% | Dec 2023 |
|
Prospect Financial Services | 273k | $669k | 7% | Mar 2024 |
|
Advisor Group Holdings | 57k | $219k | 120% | Dec 2023 |
|
Citadel Advisors | 52k | $201k | 178% | Dec 2023 |
|
TD Waterhouse Canada | 19k | $74k | 0% | Dec 2023 |
|
Nbc Securities | 14k | $34k | 100% | Mar 2024 |
|
Tocqueville Asset Management | 13k | $50k | 30% | Dec 2023 |
|
Simplex Trading | 11k | $26k | 100% | Mar 2024 |
|
Patriot Financial Group Insurance Agency | 10k | $25k | 100% | Mar 2024 |
|
Cambridge Investment Research Advisors | 10k | $25k | 100% | Mar 2024 |
|
Semmax Financial Advisors | 5.9k | $17k | 0% | Dec 2023 |
|
Cornerstone Planning Group | 3.3k | $13k | 100% | Dec 2023 |
|
Cutler | 1.3k | $2.2k | -69% | Mar 2024 |
|
Advisory Services Network | 1.2k | $4.5k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 511.00 | $2.0k | 100% | Dec 2023 |
|
GPS Wealth Strategies Group | 500.00 | $1.2k | 0% | Mar 2024 |
|
Wells Fargo & Company | 81.00 | $310.003200 | 5% | Dec 2023 |
|
Royal Bank of Canada | 53.00 | $0 | 71% | Dec 2023 |
|
Bank of America Corporation | 14.00 | $53.999400 | 100% | Dec 2023 |
|
Who sold out of Acurx Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Millennium Management | Sep 2023 | 15k | $21k |
Two Sigma Securities | Sep 2023 | 10k | $15k |
Sigma Planning | Dec 2023 | 10k | $38k |
Anchor Investment Management | Sep 2023 | 4.5k | $6.8k |